Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Gillette, Michael A., Satpathy, Shankha, Cao, Song, Dhanasekaran, Saravana M., Vasaikar, Suhas V., Krug, Karsten, Petralia, Francesca, Li, Yize +178 more·2020·Cell

Cited by (846)

Items 201–300 of 846

  1. Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
    Nathan T. Wamsley, Emily Wilkerson, Li Guan, Kyle M. LaPak, Travis Parke Schrank, Brittany Holmes, Robert W. Sprung, Petra Erdmann-Gilmore, Sophie P. Gerndt, Ryan S. Jackson et al. · 2023 · Molecular & Cellular Proteomics
  2. Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway
    Qi Dong, Tong Yu, Bo Chen, Mingyue Liu, Xiang Sun, Huiying Cao, Kaidong Liu, Huanhuan Xu, Yuquan Wang, Shuping Zhuang et al. · 2023 · JCI Insight
  3. Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation
    Xiaohang Yang, Xingyuan Hu, Jingjing Yin, Wenting Li, Yu Fu, Bin Yang, Junpeng Fan, Funian Lu, Tianyu Qin, Xiaoyan Kang et al. · 2024 · Nature Communications
  4. Extracellular Matrix Remodeling Alleviates Memory Deficits in Alzheimer's Disease by Enhancing the Astrocytic Autophagy‐Lysosome Pathway
    Qinghu Yang, Chengxiang Yan, Yahan Sun, Zhen Xie, Liang Yang, Ming Jiang, Junjun Ni, Beining Chen, Sen Xu, Zhaoyue Yuan et al. · 2024 · Advanced Science
  5. Unifying multi-sample network inference from prior knowledge and omics data with CORNETO
    Pablo Rodríguez-Mier, Martín Garrido‐Rodríguez, Attila Gábor, Julio Sáez-Rodríguez · 2025 · Nature Machine Intelligence
  6. Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts
    Juntuo Zhou, Bing Liu, Zhongwu Li, Li Yang, Xi Chen, Yuanyuan Ma, Shi Yan, Xin Yang, Lijun Zhong, Nan Wu · 2020 · Molecular & Cellular Proteomics
  7. Identification of transcriptional subtypes in lung adenocarcinoma and squamous cell carcinoma through integrative analysis of microarray and RNA sequencing data
    François Fauteux, Anuradha Surendra, Scott McComb, Youlian Pan, Jennifer J. Hill · 2021 · Scientific Reports
  8. Glutathione peroxidase 8 expression on cancer cells and cancer‐associated fibroblasts facilitates lung cancer metastasis
    Yulian Xu, Luo‐Wei Yuan, Xiaoming Jiang, Min‐Xia Su, Mu‐Yang Huang, Yu‐Chi Chen, Lele Zhang, Xiuping Chen, Hong‐Jian Zhu, Jin‐Jian Lu · 2022 · MedComm
  9. Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
    Shideh Mirhadi, Wen Zhang, Nhu‐An Pham, Fereshteh Karimzadeh, Melania Pintilie, Jiefei Tong, Paul P. Taylor, Jonathan R. Krieger, Bethany Pitcher, Jenna R. Sykes et al. · 2022 · Molecular Cancer Research
  10. Pan-Cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer Therapeutics
    Jixin Wang, Wen Yu, Rachel K. D’Anna, Anna Przybyła, Matt Wilson, Matthew S. Sung, John Bullen, Elaine M. Hurt, Gina D’Angelo, Ben S. Sidders et al. · 2023 · Molecular & Cellular Proteomics
  11. PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression
    Yi Fei Lee, Cheryl Zi Jin Phua, Ju Yuan, Bin Zhang, May Yin Lee, Srinivasaraghavan Kannan, Yui Hei Jasper Chiu, Casslynn W.Q. Koh, Choon Kong Yap, Edwin Kok Hao Lim et al. · 2024 · Genome Medicine
  12. Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response
    Lianmei Tan, Tao Yin, Handan Xiang, Liuyang Wang, Poorva Mudgal, Junying Chen, Yi Ding, Guoping Wang, Bryan Jian Wei Lim, Yuqi Huang et al. · 2024 · Nature Communications
  13. Knowledge-Guided “Community Network” Analysis Reveals the Functional Modules and Candidate Targets in Non-Small-Cell Lung Cancer
    Fan Wang, Shuqing Han, Yang Ji, Wenying Yan, Guang Hu · 2021 · Cells
  14. Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets
    Dengyun Zhao, Yaping Guo, Huifang Wei, Xuechao Jia, Yafei Zhi, Guiliang He, Wenna Nie, Limeng Huang, Penglei Wang, Kyle Vaughn Laster et al. · 2024 · JCI Insight
  15. Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites
    Wen Jiang, Eric J. Jaehnig, Yuxing Liao, Zhiao Shi, Tomer M. Yaron, Jared Lee Johnson, Lewis C. Cantley, Bing Zhang · 2025 · Nature Communications
  16. Posttranslational Modification in Bone Homeostasis and Osteoporosis
    Yuzhe Lin, Shide Jiang, Yuming Yao, Hengzhen Li, Hongfu Jin, Guang Yang, Bingzhou Ji, Yusheng Li · 2025 · MedComm
  17. Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies
    Andrea Rocca, Lucio Crinò, Luca Braga, F. Salton, B. Ruaro, M. Confalonieri, D. Generali, Paola Confalonieri · 2025 · British Journal of Cancer
  18. HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma
    Tian Tian, Hong Yu Fu, Zhiwen Wang, Jiaru Hu, Ni Chen, Lei Lv, Qiyi Yi · 2021 · Cell Death Discovery
  19. A Brave New World: Virtual Reality and Augmented Reality in Systems Biology
    Berk Turhan, Zeynep Hulya Gumus · 2022 · Frontiers in Bioinformatics
  20. A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma
    Bo Tang, Lanlin Hu, Tao Jiang, Yunchang Li, Huasheng Xu, Hang Zhou, Mei Lan, Ke Xu, Jun Yin, Chunxia Su et al. · 2022 · International Journal of Molecular Sciences
  21. Exploring the pan-cancer landscape of posttranscriptional regulation
    Umesh Ghoshdastider, Ataman Sendoel · 2023 · Cell Reports
  22. Identification of the consistently differential expressed hub mRNAs and proteins in lung adenocarcinoma and construction of the prognostic signature: a multidimensional analysis
    Yiran Liu, Zhenyu Li, Qianyao Meng, Anhui Ning, Shenxuan Zhou, Siqi Li, Xiaobo Tao, Yutong Wu, Qiong Chen, Tian Tian et al. · 2023 · International Journal of Surgery
  23. Integration of proteomics in the molecular tumor board
    Johanna Thiery, Matthias Fahrner · 2023 · PROTEOMICS
  24. A highly multiplexed quantitative phosphosite assay for biology and preclinical studies
    Hasmik Keshishian, E. Robert McDonald, Filip Mundt, Randy Melanson, Karsten Krug, DALE A. PORTER, Luke Wallace, Dominique Forestier, Bokang Rabasha, Sara Marlow et al. · 2021 · Molecular Systems Biology
  25. Epigenome signature as an immunophenotype indicator prompts durable clinical immunotherapy benefits in lung adenocarcinoma
    Pan Xu, Caiyu Zhang, Junwei Wang, Peng Wang, Yue Gao, Shipeng Shang, Shuang Guo, Xin Li, Hui Zhi, Shangwei Ning · 2021 · Briefings in Bioinformatics
  26. Proteomic Stratification of Prognosis and Treatment Options for Small Cell Lung Cancer
    Zitian Huo, Yaqi Duan, Dongdong Zhan, Xizhen Xu, Nairen Zheng, Jing Cai, Ruifang Sun, Jianping Wang, Fang Cheng, Zhan Cheng Gao et al. · 2024 · Genomics Proteomics & Bioinformatics
  27. Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study
    Wei Nie, Jun Lü, Jie Qian, Shuyuan Wang, Lei Cheng, Zheng Liang, Guangyu Tao, Xueyan Zhang, Tianqing Chu, Baohui Han et al. · 2024 · BMC Medicine
  28. Comprehensive PTM profiling with SCASP-PTM uncovers mechanisms of p62 degradation and ALDOA-mediated tumor progression
    Zhan-Peng Lin, Guohong Gan, Xiao Xu, Chengwen Wen, Xin Ding, Xiangyu Chen, Kaijie Zhang, Wenyu Guo, Mingxin Lin, Yu-Yang Wang et al. · 2025 · Cell Reports
  29. Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation in non-small-cell-lung-cancer patients
    Tamara Tomin, Sophie Elisabeth Honeder, Laura Liesinger, Daniela Gremel, Bernhard Retzl, Joerg Lindenmann, Luka Brčić, Matthias Schittmayer, Ruth Birner‐Gruenberger · 2025 · Nature Communications
  30. A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma
    William Zhao, Thinh T. Nguyen, Atharva Bhagwat, Akhil Kumar, Bruno Giotti, Benjamin Kepecs, Jason L. Weirather, Navin R. Mahadevan, Åsa Segerstolpe, Komal Dolasia et al. · 2025 · Nature Cancer
  31. Altered expression of ACOX2 in non-small cell lung cancer
    Jane Sze Yin Sui, Petra Martin, Anna Keogh, Pierre Murchan, Lisa Ryan, Siobhan A. Nicholson, Sinead D. Cuffe, Pilib Ó Broin, Stephen P. Finn, Gerard J. Fitzmaurice et al. · 2022 · BMC Pulmonary Medicine
  32. NAGS, CPS1, and SLC25A13 (Citrin) at the Crossroads of Arginine and Pyrimidines Metabolism in Tumor Cells
    Melissa Owusu-Ansah, Nikita Guptan, Dylon Alindogan, Michio Morizono, Ljubica Caldovic · 2023 · International Journal of Molecular Sciences
  33. Skeletal muscle omics signatures in cancer cachexia: perspectives and opportunities
    Linda Anne Gilmore, Traci L. Parry, Gwendolyn A. Thomas, Andy V. Khamoui · 2023 · JNCI Monographs
  34. Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function
    Carlo P. Ramil, Handan Xiang, Peng Zhang, Aileen Cronin, Lisia Cabral, Zhizhang Yin, Josephine Hai, Huijun Wang, Benjamin Ruprecht, Yanlin Jia et al. · 2024 · OncoImmunology
  35. Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to Promote Lung Cancer Progression
    Kun Wang, Jingzhuo Li, Hai Zhang, Hongyan Ma, Hong‐Yong Cui, Huai‐Qiang Ju, Jing Zhang, Qing-zhi Ma, Ming Zhao, Qing-mei Zeng et al. · 2025 · Cancer Research
  36. Hijacking ERAD for targeted degradation of transmembrane proteins
    Haikun Song, Wei Wang, Tingfang Mei, Huiwen Zheng, Keni Ning, Xia Liu, Siulam Cheung, Zhiyuan Cao, Danqi Sheng, Xiaohan Mai et al. · 2026 · Cell
  37. SIMSI-Transfer: Software-Assisted Reduction of Missing Values in Phosphoproteomic and Proteomic Isobaric Labeling Data Using Tandem Mass Spectrum Clustering
    Firas Hamood, Florian P Bayer, Mathias Wilhelm, Bernhard Küster, Matthew The · 2022 · Molecular & Cellular Proteomics
  38. Integrated Machine Learning and Bioinformatic Analyses Constructed a Network Between Mitochondrial Dysfunction and Immune Microenvironment of Periodontitis
    Hang Chen, Limin Peng, Zhenxiang Wang, Yujuan He, Xiaonan Zhang · 2023 · Inflammation
  39. PANOPLY: a cloud-based platform for automated and reproducible proteogenomic data analysis
    D.R. Mani, Myranda Maynard, Ramani Bhupendra Kothadia, Karsten Krug, Karen E. Christianson, David I. Heiman, Karl R. Clauser, Chet Birger, Gad A. Getz, Steven A. Carr · 2021 · Nature Methods
  40. Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods
    Xia Li, Haiwei Zuo, Li Zhang, Qiuwen Sun, Yong Xin, Longzhen Zhang · 2021 · Frontiers in Oncology
  41. Mapping the O-GlcNAc Modified Proteome: Applications for Health and Disease
    Rajan A. Burt, Ibtihal M. Alghusen, Sophiya John Ephrame, M. T. Villar, A. Artigues, Chad Slawson · 2022 · Frontiers in Molecular Biosciences
  42. Comparative Proteomic Analysis of Glycolytic and Oxidative Muscle in Pigs
    Xiaofan Tan, Yu He, Yuqiao He, Zhiwei Yan, Jing Chen, Ruixue Zhao, Xin Sui, Lei Zhang, Xuehai Du, David M. Irwin et al. · 2023 · Genes
  43. Using long-read CAGE sequencing to profile cryptic-promoter-derived transcripts and their contribution to the immunopeptidome
    Ju Heon Maeng, H. Josh Jang, Alan Y. Du, Shin‐Cheng Tzeng, Ting Wang · 2023 · Genome Research
  44. Integrated proteomic and glycoproteomic analysis reveals heterogeneity and molecular signatures of brain metastases from lung adenocarcinomas
    Yang Chun Zhao, Dainan Zhang, Bo Meng, Yong Zhang, Shunchang Ma, Jiaming Zeng, Xi Wang, Tao Peng, Xiaoyun Gong, Rui Zhai et al. · 2024 · Cancer Letters
  45. Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point
    Cena Aram, Maryam Barancheshmeh, Ali Alishvandi, Mohammad H. Khodabandehloo, Alireza H. Shirvani, Amirhasan Fotohi, Mohammad Amin Ghezel, Amirhossein Borji, Masoud Keikha · 2025 · Molecular Diversity
  46. A community effort to identify and correct mislabeled samples in proteogenomic studies
    Seungyeul Yoo, Zhiao Shi, Bo Wen, Soon Jye Kho, Renke Pan, Hanying Feng, Hong Chen, Anders Carlsson, Patrik Edén, Weiping Ma et al. · 2021 · Patterns
  47. A New Era of Integration between Multiomics and Spatio-Temporal Analysis for the Translation of EMT towards Clinical Applications in Cancer
    Adilson Fonseca Teixeira, Siqi Wu, Rodney Brian Luwor, Hong‐Jian Zhu · 2023 · Cells
  48. A common druggable signature of oncogenic c-Myc, mutant KRAS and mutant p53 reveals functional redundancy and competition among oncogenes in cancer
    Maria Grzes, Akanksha Jaiswar, Marcin Grochowski, Weronika Wojtyś, Wojciech Kaźmierczak, Tomasz Olesiński, Małgorzata Lenarcik, Magdalena Nowak-Niezgoda, Małgorzata Kołos, Giulia Canarutto et al. · 2024 · Cell Death and Disease
  49. Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy
    Yuqing Ren, Yi Yue, Xinyang Li, Siyuan Weng, Hui Xu, Long Liu, Quan Cheng, Peng Luo, Tengfei Zhang, Zaoqu Liu et al. · 2024 · International Immunopharmacology
  50. A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival
    Sipeng Shen, Yongyue Wei, Yi Li, Weiwei Duan, Xuesi Dong, Lijuan Lin, Dongfang You, Adonina Tardón, Chu Chen, John K. Field et al. · 2021 · npj Precision Oncology
  51. Transcriptome features of striated muscle aging and predictability of protein level changes
    Han Yu, Lauren Z. Li, Nikhitha Kastury, Cody T. Thomas, Maggie P. Y. Lam, Edward Lau · 2021 · Molecular Omics
  52. Comprehensive Analysis of CDK1-Associated ceRNA Network Revealing the Key Pathways LINC00460/LINC00525-Hsa-Mir-338-FAM111/ZWINT as Prognostic Biomarkers in Lung Adenocarcinoma Combined with Experiments
    Wen Li, Shanshan Feng, Hao Wu, Jing Deng, Wang-Yan Zhou, Mingxi Jia, Yi Shi, Liang Ma, Xiaoxi Zeng, Zavuga Zuberi et al. · 2022 · Cells
  53. Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
    Nicole Woldmar, A. Schwendenwein, Magdalena Kuras, Beáta Szeitz, Kristiina Boettiger, Anna Tisza, Viktória László, Lilla Reiniger, Attila György Bagó, Zoltán Szállási et al. · 2022 · ESMO Open
  54. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
    Nicholas W. Bateman, Christopher M. Tarney, Tamara S. Abulez, Anthony R. Soltis, Ming Zhou, Kelly A. Conrads, Tracy A. Litzi, Julie Oliver, Brian L. Hood, Paul H. Driggers et al. · 2021 · Scientific Reports
  55. BlackSheep: A Bioconductor and Bioconda Package for Differential Extreme Value Analysis
    Lili M. Blumenberg, Emily A. Kawaler, MacIntosh Cornwell, Shaleigh A. Smith, Kelly V. Ruggles, David Fenyö · 2021 · Journal of Proteome Research
  56. Proteome-based pathology: the next frontier in precision medicine
    Michael H. A. Roehrl, Victor B. Roehrl, Julia Y. Wang · 2020 · Expert Review of Precision Medicine and Drug Development
  57. Synergy of EGFR and AURKA Inhibitors in <i>KRAS</i> -mutated Non–small Cell Lung Cancers
    Bagnyukova, Tetyana, Egleston, Brian L., Pavlov, Valerii A., Serebriiskii, Ilya G., Golemis, Erica A., Borghaei, Hossein · 2024 · Cancer Research Communications
  58. Comparative analysis of integrative classification methods for multi-omics data
    Alexei Novoloaca, Camilo Broc, Laurent Belœil, Wen‐Han Yu, Jérémie Becker · 2024 · Briefings in Bioinformatics
  59. Proteomics and EPS Compositional Analysis Reveals Desulfovibrio bisertensis SY-1 Induced Corrosion on Q235 Steel by Biofilm Formation
    Yanan Wang, Ruiyong Zhang, Krishnamurthy Mathivanan, Yimeng Zhang, Luhua Yang, Fang Guan, Jizhou Duan · 2024 · Materials
  60. High-Throughput Proteomic and Phosphoproteomic Analysis of Formalin-Fixed Paraffin-Embedded Tissues
    Moe Haines, John R Thorup, Simone B. Gohsman, Claudia Ctortecka, Chelsea J. Newton, Daniel C. Rohrer, Galen H. Hostetter, D.R. Mani, Michael A. Gillette, Shankha Satpathy et al. · 2025 · Molecular & Cellular Proteomics
  61. Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers
    Guizhen Wang, Zheng Wang, Shihao Bai, Yun Tan, Wen‐Zhao Zhong, Guogui Sun, Yutao Liu, Bo Pan, Chen Huang, Di Wang et al. · 2025 · Signal Transduction and Targeted Therapy
  62. An Interpretable Machine Learning Model for Predicting 5‐Year Survival in Breast Cancer Based on Integration of Proteomics and Clinical Data
    Zhixuan Wu, Shengnan Yao, Lingli Jin, Xue Wu, Rongrong Zhang, Ouchen Wang, Erjie Xia · 2025 · iMetaMed
  63. Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer
    Siddhartha H. K. Devarakonda, Ramaswamy Govindan, Daniel Morgensztern · 2020 · Cancer Cell
  64. Exploration of the Key Proteins of High-Grade Intraepithelial Neoplasia to Adenocarcinoma Sequence Using In-Depth Quantitative Proteomics Analysis
    Yin Zhang, Chunyuan Li, Meng Pan, Jingying Li, Wei Ge, Lai Xu, Yi Xiao · 2021 · Journal of Oncology
  65. Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
    Silvana Andrea Mouron, María J. Bueno, Ana M. Lluch, Luís Manso, Isabel Calvo, Javier Cortés, José Á. García-Sáenz, Miguel Gil‐Gil, Noelia Martínez-Jáñez, Juan V. Apala et al. · 2022 · Nature Communications
  66. Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma
    Do Thi Minh Xuan, I‐Jeng Yeh, Che‐Yu Su, Hsin-Liang Liu, Hoang Dang Khoa Ta, Gangga Anuraga, Chung-Chieh Chiao, Chih‐Yang Wang, Meng‐Chi Yen · 2022 · International Journal of Medical Sciences
  67. Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models
    Yizhen Guo, Yan Zhou, Puhua Wu, Maoxin Ran, Ngai Xu, Wenying Shan, Ou Sha, Kin Yip Tam · 2023 · Chemico-Biological Interactions
  68. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
    Seung‐Jin Park, Shinyeong Ju, Sung‐Ho Goh, Byoung-Ha Yoon, Jong‐Lyul Park, Jeong‐Hwan Kim, Seonjeong Lee, Sang-Jin Lee, Yu Mi Kwon, Wonyeop Lee et al. · 2024 · Cancer Research
  69. Extracellular Matrix Sulfation in the Tumor Microenvironment Stimulates Cancer Stemness and Invasiveness
    Alican Kuşoğlu, Deniz Örnek, Aslı Dansık, Ceren Uzun, Sena Nur Özkan, Sevgi Sarıca, Kardelen Yangın, Şevval Özdinç, Duygu Turan Sorhun, Nuriye Solcan et al. · 2024 · Advanced Science
  70. Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations
    Ichidai Tanaka, Masahiro Morise · 2021 · International Journal of Molecular Sciences
  71. Curcumin: A potential therapeutic natural product for adenocarcinomas
    Mahshid Moballegh Nasery, Mohammad Varzandeh, Saghar Pahlavanneshan, Neda Mohamadi, Solmaz Sarhadi, Hojjat Samareh Fekri, Reza Mohammadinejad, Kwang Seok Ahn · 2022 · Phytochemistry Letters
  72. Deep Learning and Its Applications in Computational Pathology
    Hong, Runyu, Fenyö, David · 2022 · BioMedInformatics
  73. In Situ MXene-Controlled Synthesis of Polycrystalline TiO2 for Highly Efficient Enrichment of Phosphopeptides
    Feifei Xu, Danyi Shang, Congcong Zhu, Gaohui Du, Jingchen Shi, Xuefang Dong, Xiuling Li, Xinmiao Liang · 2024 · ACS Applied Materials & Interfaces
  74. Cancer biomarkers discovered using pan-cancer plasma proteomic profiling
    Lin Bai, Jiacheng Lyu, Jinwen Feng, Xiaoqiang Qiao, Yuanyuan Qu, Guojian Yang, Yuanxue Zhu, Lingxiao Liao, Hui Yuan Gao, Aimin Zang et al. · 2025 · Nature Biomedical Engineering
  75. Elucidating cellular origins and TME dynamic evolution in NSCLC through multi-omics technologies
    Ning Ning Chao, Li Zhang · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  76. Statistical Detection of Differentially Abundant Proteins in Experiments with Repeated Measures Designs and Isobaric Labeling
    Ting C. Huang, Mateusz Staniak, Felipe da Veiga Leprevost, Amanda M. Figueroa‐Navedo, Alexander R. Ivanov, Alexey I. Nesvizhskii, Meena Choi, Olga Vitek A · 2023 · Journal of Proteome Research
  77. Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling
    Dong Zhang, Rui Sun, C. Di, Lin Li, Faming Zhao, Yu Han, Wenjie Zhang · 2023 · Computers in Biology and Medicine
  78. Tailoring pretext tasks to improve self-supervised learning in histopathologic subtype classification of lung adenocarcinomas
    Ruiwen Ding, Anil Yadav, Erika F. Rodriguez, Ana Cristina Araújo Lemos da Silva, William W.Y. Hsu · 2023 · Computers in Biology and Medicine
  79. Cancer-Associated Endocrine Cells Participate in Pancreatic Carcinogenesis
    Yuan Chen, Xinpeng Yin, Ruiyuan Xu, Rexiati Ruze, Jianlu Song, Chenxue Yin, Chenglin Hu, Chengcheng Wang, Qiang Xu, Zhao Yupei · 2024 · Gastroenterology
  80. ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer
    Maria A. Voronkova, B. Johnson, Nishant S. Gandhi, J. M. Koomen, M Patrick, Santhosh Shanthi Bhupathi, V. M. Wu, Andrew Elliott, Ari M. Vanderwalde, Balázs Halmos et al. · 2024 · npj Precision Oncology
  81. Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration
    Anurima Majumder, Sina Hosseinian, Mia Stroud, Emma Adhikari, James Joseph Saller, Matthew A. Smith, Guolin Zhang, Shruti Agarwal, Marc Creixell, Benjamin S. Meyer et al. · 2022 · Molecular Cancer Research
  82. Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
    Alessandro Di Federico, Andrea De Giglio, Francesco Gelsomino, Dario de Biase, Francesca Giunchi, Arianna Palladini, Francesca Sperandi, Barbara Melotti, Andrea Ardizzoni · 2022 · Cancers
  83. MiRNA-144–5p down-modulates CDCA3 to regulate proliferation and apoptosis of lung adenocarcinoma cells
    Jing Wan Luo, Lilong Xia, Lei Zhang, Kaixiang Zhao, Chuanchuan Li · 2022 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  84. Angiogenesis goes computational – The future way forward to discover new angiogenic targets?
    Abhishek Subramanian, Pooya Zakeri, Mira Mousa, Halima Alnaqbi, Fatima Yousif Alshamsi, Leo Bettoni, Ernesto Damiani, Habiba S. AlSafar, Yvan Saeys, Peter Carmeliet · 2022 · Computational and Structural Biotechnology Journal
  85. Inflammation-related citrullination of matrisome proteins in human cancer
    Pekka Rappu, Ujjwal Suwal, Elina Siljamäki, Jyrki Heino · 2022 · Frontiers in Oncology
  86. Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy
    Laura Torresano, Fulvio Santacatterina, Sonia Domínguez-Zorita, Cristina Nuevo‐Tapioles, Alfonso Núñez-Salgado, Pau B. Esparza‐Moltó, Lucía González-Llorente, Inés Romero-Carramiñana, Cristina Núñez de Arenas, Brenda Sánchez-Garrido et al. · 2022 · Oncogenesis
  87. BayesDeBulk: A Flexible Bayesian Algorithm for the Deconvolution of Bulk Tumor Data
    Francesca Petralia, Azra Krek, Anna Pamela Calinawan, Daniel Charytonowicz, Robert Sebra, Song Feng, Sara J.C. Gosline, Pietro Pugliese, Amanda G. Paulovich, Jacob J. Kennedy et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Cancer genomics and bioinformatics in Latin American countries: applications, challenges, and perspectives
    Erika Sofia Torres-Narvaez, D. González, Juan Andrés Artunduaga-Alvarado, Oscar Ortega‐Recalde · 2025 · Frontiers in Oncology
  89. Harnessing multi-omics approaches to decipher tumor evolution and improve diagnosis and therapy in lung cancer
    Yi Cheng, Ling Bai, Jiuwei Cui · 2025 · Biomarker Research
  90. Proteome and Transcriptome Analysis of Gonads Reveals Intersex in Gigantidas haimaensis
    Yu Shi, Gaoyou Yao, Hua Zhang, Huixia Jia, Panpan Xiong, Maoxian He · 2022 · BMC Genomics
  91. Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity
    Zhong Xian, Jingzhuo Tian, Yong Zhao, Yi Yan, Chunying Li, Jiayin Han, Yushi Zhang, Yuan Wang, Lianmei Wang, Suyan Liu et al. · 2023 · Phytomedicine
  92. POLRMT over‐expression is linked to WNT /beta‐catenin signaling, immune infiltration, and unfavorable outcomes in lung adenocarcinoma patients
    Yongkang Huang, Yajuan Qian, Yufei Xing, Yongjian Pei, Beilei Zhang, Ting Li, Xue Pan, Anyuan Zhong, Juan Du, Tong Zhou et al. · 2023 · Cancer Medicine
  93. Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
    Ichidai Tanaka, Junji Koyama, Hideyuki Itoigawa, Shunsaku Hayai, Masahiro Morise · 2023 · Frontiers in Oncology
  94. Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
    Duc Tran, J. Scott Beeler, Jie Liu, Brian J. Wiley, Irenaeus C.C. Chan, Zilan Xin, Michael H. Kramer, Armel Landry Batchi-Bouyou, Xiaoyu Zong, Matthew J. Walter et al. · 2024 · Clinical Cancer Research
  95. Proteomics appending a complementary dimension to precision oncotherapy
    Zhaokai Zhou, Ruiqi Zhang, Aoyang Zhou, Jinxiang Lv, Shuang Chen, Haijiao Zou, Ge Zhang, Ting Lin, Zhan Wang, Yuyuan Zhang et al. · 2024 · Computational and Structural Biotechnology Journal
  96. Pan‐cancer proteogenomic landscape of whole‐genome doubling reveals putative therapeutic targets in various cancer types
    Eunhyong Chang, Su‐Jung Kim, Hee Sang Hwang, Kyu Jin Song, Kwoneel Kim, Min‐Sik Kim, Se Jin Jang, Sungyong You, Kwang Pyo Kim, Joon‐Yong An · 2024 · Clinical and Translational Medicine
  97. Combination of transcriptomic and proteomic approaches helps unravel the mechanisms of luteolin in inducing liver cancer cell death via targeting AKT1 and SRC
    Junxia Ma, Jinggang Mo, Yifu Feng, Liezhi Wang, Hao Jiang, Junmin Li, Chong Jin · 2024 · Frontiers in Pharmacology
  98. Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunities
    Honglei Zhang, Chao Liu, Shuting Wang, Qing Wang, Feng Xu, Hua‐Wei Jiang, Xiao Li, Chao Luo, Lu Zhang, Fei Hou et al. · 2024 · eLife
  99. Xiaoqinglong decoction combined with Yupingfeng powder alleviates combined allergic rhinitis and asthma syndrome by regulating the JAK2-STAT1-MHC II signaling pathway to suppress B lymphocyte activation
    Ruizhi Wang, Zhe Xiao, Xunqing Shi, Fan Ye, Junhai Chen, Min Dong, Huijun Qiu, Yana Zhang, Jianbo Shi, Min Zhou et al. · 2025 · Journal of Ethnopharmacology
  100. The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD
    Yinggang Che, Dongbo Jiang, Leidi Xu, Yuanjie Sun, Yingtong Wu, Yang Liu, Ning Chang, Jiangjiang Fan, Hangtian Xi, Dan Qiu et al. · 2022 · Frontiers in Immunology